Menstrual Migraine : How Hormones Impact Migraine
(1) Neurology Department, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang
(2) Sub Division of Oncology Gynecology, Obstetrics and Gynecology Department, Faculty of Medicine, Andalas University, Dr. M. Djamil Central General Hospital Padang
(*) Corresponding Author
DOI: https://doi.org/10.25077/aoj.5.1.9-17.2021
Abstract
Menstrual Migraine is divided into 2 subtypes: Menstrually Related Migraine (MRM) and Pure Menstrual Migraines (PMM). In PMM symptoms do not occur outside the menstrual cycle while MRM, symptoms can occur at other times apart from the menstrual cycle. The occurrence of menstrual migraines is related to the female hormones cycle in the form of the decrease in estrogen levels which usually occurs a week before the onset of menstruation. The mechanism is unclear, but it is thought that a decrease in estrogen levels can trigger decrease in serotonin levels, causing cranial vasodilation and sensitization of the trigeminal nerve.
Keywords: menstrual migraine, hormonesFull Text:
PDFReferences
Sjahrir, Hasan. Nyeri Kepala. Kelompok Studi Nyeri Kepala. Perhimpunan Dokter Spesialis Saraf Indonesia. 2004
Price, Sylvia dan Lorraine M.Wilson. Patofisiologi edisi 6.Jakarta EGC.2003.
Headache Classification Subcommitee of the International Headache Society. The International Headache Classification Disorder: 2nd Edition. Cephalgia 2004; 24 Suppl 1:1-160.
Fernandez-de-las-Peas. C., Chaitow.L & Schoenen.J. Multidisciplinary management of migrain.Jones & Bartlett Learning. J Headache Pain. 2012 Nov;13:689
Mayo Clinic. Disease and Conditions Migraine. Available at : http://www.mayoclinic.org/diseasesconditions/migraineheadache/basics/causes/con-20026358. [cited March 10, 2014]
Vertik, K. G., MacGregor, E. A., Lundqvist, C. & Russel, M. B. Prevalence of Menstrual Migraine: A Population-Based Study. Cephalgia: An International Journal of Headache.2014. 34(4), pp. 280-288.
MacGregor, E. A. Menstrual Migraine: A Clinical Review. Journal Fam Plann Reprod Health Care. 2007; 33:36-47
MacGregor, A. E., 2009. Review: Menstrual Migrain: Therapeutic Approach. Therapeutic Advances in Neurological Disorders.2009:2(5), pp. 327-36.
Kaur, K. K. Menstrual Migraine-A Mini Review. Journal of Gynaecology.2017:1(12), pp. 1-7.
Irish College of General Practioners. Migraine: diagnosis and management from a GP perspective.2019. https://www.icgp.ie/speck/properties/asset/asset.cfm?- cited 30 Mei 2020
Borsook D, Erpelding N, Lebel A, et al. Sex and the migrene brain. Neurobiol Dis. 2014;68:200-214.
Turner DP, Lebowitz AD, Chtay I, Houle TT. Forecasting migrene attacks and the utility of identifying triggers. Curr Pain Headache Rep. 2018;22:62.
Gerber MR, Fried LE, Pineles SL, Shipherd JC, Bernstein CA. Posttraumatic stress disorder and intimate partner violence in a women’s headache center. Women Health. 2012;52:454-471.
Tietjen GE, Khubchandani J, Herial NA, Shah K. Adverse childhood experiences are associated with migrene and vascular biomarkers. Headache. 2012;52:920-929.
Lee S, Tsang A, Von Korff M, et al. Association of headache with childhood adversity and mental disorder: Cross-national study. Br J Psychiatry. 2009; 194:111-116.
Babu J, Bensen J, Thomas J, Raju L, Fathima N. Association of migrene and hormones during menstruation, pregnancy and menopause. Indo Am J Pharm. 2019. 9(3): 1994-99.
MacGregor EA, Hackshaw A. Prevention of migrene in the pill-free interval of combined oral contraceptives: a double-blind, placebo-controlled pilot study using natural oestrogen supplements. J Fam Plann Reprod Health Care 2002;28(1):27-31.
Headache Classification Committee of the International Headache Society (IHS). The international classification of headache disorders, (beta version). Cephalalgia. 2013 Jul;33(9):629-808.
Chai NC, Peterlin BL, Calhoun AH. Migrene and estrogen. Existingview in neurology. 2014 Jun;27(3):315.
Calhoun AH. Menstrual migrene: update on pathophysiology and method oftreatment and management. Current treatment choices in neurology. 2012 Feb 1;14(1):1-4.
National Headache Foundation. Menstrual migraines.2019.Headache.org
Vincent T. Martin M. Menstrual Migraine: New Approaches to Diagnosis and Treatment. Am Headache Soc. 2018
MacGregor EA. Diagnosis and management of menstrual migraine. Prog Neurol Psychiatry. 2011; 15:11-16
ICHD-3. 2018. The International Classification of Headache Disorders 3rd edition. International Headache Society.38(1).
Hu Y, Guan X, Fan L et al. Triptans in prevention of menstrual migraine: a systematic review with meta-analysis. J Headache Pain 2013;14:7-15.
NICE. NICE Guideline CG150: Headache in over 12s: diagnosis and management. 2015.http://www.nice.org.uk
Casolla B, Lionetto L, Candela S et al. Treatment of perimenstrual migraine with triptans: an update. Curr Pain Headache Rep. 2012; 16(5):445-51.
Tepper SJ, Tepper D. The Cleveland Clinic Manual of Headache Therapy. 2nd ed. Switzerland: Springer International Publishing; 2014.pp:3-17
Warhurst S, Rofe CJ, Brew BJ, Bateson D, McGeechan K, Merki-Feld GS, et al. Effectiveness of the progestin-only pill for migraine treatment in women: A systematic review and meta-analysis. Cephalalgia. 2018; 38(4):754-764.
Kaerney M, Ruttledge M, Tomkins E. Migraine: Diagnosis and Management from a GP Perspective. Ireland: ICGP; 2019
Daly P. Chapter 5: Headaches in General Practice & Women and migraine. In: Murray M, Little P, Craven A, editors. Migraine: Not just another headache. Dublin: Columba Press; 2016.
Nappi RE, Kaunitz AM, Bitzer J. Extended regimen combined oral contraception: A review of evolving concepts and acceptance by women and clinicians. Eur J Contracept Reprod Health Care. 2016;21:106-115.
Refbacks
- There are currently no refbacks.
Address for Correspondence: